CREDIT SUISSE AG/ - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 152 filers reported holding ARCUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$780,646
-31.5%
43,490
-22.5%
0.00%0.0%
Q2 2023$1,140,366
+80.7%
56,148
+62.3%
0.00%0.0%
Q1 2023$630,976
-18.6%
34,593
-7.7%
0.00%0.0%
Q4 2022$775,065
-24.1%
37,479
-3.9%
0.00%0.0%
Q3 2022$1,021,000
+36.9%
38,985
+32.5%
0.00%0.0%
Q2 2022$746,000
-26.3%
29,433
-8.2%
0.00%0.0%
Q1 2022$1,012,000
-26.0%
32,061
-5.1%
0.00%0.0%
Q4 2021$1,367,000
+18.7%
33,784
+2.2%
0.00%0.0%
Q3 2021$1,152,000
+38.1%
33,055
+8.1%
0.00%
Q2 2021$834,000
-8.3%
30,568
-5.6%
0.00%
Q1 2021$909,000
-45.8%
32,370
-49.9%
0.00%
-100.0%
Q4 2020$1,676,000
-4.8%
64,557
-37.1%
0.00%0.0%
Q3 2020$1,760,000
+7.4%
102,687
+55.1%
0.00%0.0%
Q2 2020$1,638,000
+695.1%
66,194
+348.3%
0.00%
Q1 2020$206,000
+79.1%
14,767
+29.3%
0.00%
Q4 2019$115,000
-26.8%
11,422
-33.8%
0.00%
Q3 2019$157,000
+28.7%
17,264
+12.2%
0.00%
Q2 2019$122,000
-46.3%
15,387
-15.6%
0.00%
Q1 2019$227,000
+58.7%
18,225
+37.8%
0.00%
Q4 2018$143,00013,2290.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$65,241,00019.83%
Octagon Capital Advisors LP 2,095,231$84,794,00016.50%
EcoR1 Capital, LLC 5,523,358$223,530,0007.12%
BVF INC/IL 3,398,067$137,520,0004.99%
PFM Health Sciences, LP 3,431,010$138,853,0004.73%
Alphabet Inc. 2,563,441$103,742,0002.50%
Boxer Capital, LLC 1,432,200$57,961,0002.25%
PARK CIRCLE Co 64,000$2,590,0002.04%
SECTORAL ASSET MANAGEMENT INC 283,210$11,462,0001.72%
DAFNA Capital Management LLC 117,200$4,743,0001.19%
View complete list of ARCUS BIOSCIENCES INC shareholders